Defining therapeutic cells as well as establishing cell targeting and tracking technology for the treatment of myocardial infarction and atherosclerosis.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1070860

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Regenerative cell therapy holds great promise for many diseases. However, studies so far such as preventing and treating heart attacks, often showed limited success. We will address the current three limitations of regenerative cell therapy: 1) Identify the beneficial “therapeutic” cell type. 2) Develop a technology that selectively delivers cells to the area of need. 3) Develop cell tracking technology. This study has the potential to provide major advances in regenerative cell therapy.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2016

Funding Scheme: Project Grants

Funding Amount: $664,611.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

atherosclerosis | molecular imaging | myocardial infarction | regenerative medicine | targeting

Related Links